Collapsing FSGS (APOL1)
(Die Seite wurde neu angelegt: „anchor is Collapsing FSGS {{tp|p=30624253|t=2019. One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.|pdf=|usr=}} {{tp|p=3102…“)
Aktuelle Version vom 1. September 2020, 08:36 Uhr
anchor is Collapsing FSGS
30624253 2019. One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.
31023447 2019. The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
25168832 2014. APOL1 kidney risk alleles: population genetics and disease associations.
31601430 2020. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
30054024 2019. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
30343724 2018. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
22119407 2012. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
20137840 2010. Reappraisal of the impact of race on survival in patients on dialysis.
26343748 2015. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
22965004 2012. Relevance of the ACTN4 gene in African-Americans with non-diabetic end-stage renal disease.
30201495 2018. Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.
30201493 2018. APOL1-miR-193 Axis as a Bifunctional Regulator of the Glomerular Parietal Epithelium: Maintaining Parietal Cell Phenotype versus Promoting Podocyte Differentiation.
30332315 2019. APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
31241995 2019. APOL1 and kidney cell function.
29357419 2018. Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu.
25809272 2015. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
21486385 2011. The APOL1 gene and allograft survival after kidney transplantation.
24504811 2014. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
27600725 2016. Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation.
25281610 2015. The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.
26668025 2016. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
24903390 2014. Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
22068337 2012. Target organ damage in African American hypertension: role of APOL1.
29389775 2018. Apolipoprotein L1 nephropathies: 2017 in review.
21453219 2011. Effects of race on albuminuria and risk of cardiovascular and kidney disease.
22569246 2012. Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.
26106375 2015. Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN).
30890594 2019. Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life.
20635188 2010. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
27035887 2016. Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection.
28335839 2017. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
29180397 2018. ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.
28696248 2017. Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy Depletion.
27864430 2017. APOL1-G1 in Nephrocytes Induces Hypertrophy and Accelerates Cell Death.
27821631 2017. APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction.
27005919 2016. Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort.
25788523 2015. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
25573910 2015. Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
25573908 2015. Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
25012173 2015. Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.
26038529 2015. APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.
24309185 2014. The kidney as a reservoir for HIV-1 after renal transplantation.
24722442 2014. Explaining the racial difference in AKI incidence.
23813212 2013. APOL1 and progression of nondiabetic nephropathy.
23520206 2013. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.
21997397 2011. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
21997394 2011. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
21997392 2011. APOL1 localization in normal kidney and nondiabetic kidney disease.
20688934 2010. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
30052698 2018. APOL1 risk variants and kidney disease: what we know so far.
21881214 2011. Genetics of kidney failure and the evolving story of APOL1.
29971324 2018. Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women.
31217349 2019. Antisense oligonucleotide treatment ameliorates IFN-gamma-induced proteinuria in APOL1-transgenic mice.
29903699 2018. A Putative Role of Apolipoprotein L1 Polymorphism in Renal Parenchymal Scarring Following Febrile Urinary Tract Infection in Nigerian Under-Five Children: Proposal for a Case-Control Association Study.
30466562 2018. Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.
30287079 2018. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
25993319 2015. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
25853332 2015. APOL1 toxin, innate immunity, and kidney injury.
25029429 2015. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
25635718 2015. Immunity unmasks APOL1 in collapsing glomerulopathy.
25100047 2015. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.
25826538 2015. Should kidney donors be genotyped for APOL1 risk alleles?
22832513 2013. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
24280748 2013. JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene x environment interaction?
23677244 2013. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
22695330 2012. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
31317114 2019. APOL1-Associated Kidney Disease in Brazil.
31317111 2019. Searching for Second Hits for the Development of APOL1-Associated Kidney Disease.
28391347 2017. Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte.
22302261 2012. The new era of APOL1-associated glomerulosclerosis.
21931123 2011. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
27494254 2016. A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.
28850570 2017. Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
27138898 2016. Knockdown of ApoL1 in Zebrafish Larvae Affects the Glomerular Filtration Barrier and the Expression of Nephrin.
24658608 2014. MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.
26699492 2016. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
31838940 2020. Variation of ApoL1 Testing Practices for Living Kidney Donors.
28494221 2017. Does copy number variation of APOL1 gene affect the susceptibility to focal segmental glomerulosclerosis?
27599995 2016. Impact of APOL1 polymorphism and IL-1beta priming in the entry and persistence of HIV-1 in human podocytes.
31664093 2019. Nucleosomal dsDNA Stimulates APOL1 Expression in Human Cultured Podocytes by Activating the cGAS/IFI16-STING Signaling Pathway.
29110760 2017. Apolipoprotein L1 Gene Effects on Kidney Transplantation.
29110758 2017. APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.
26215860 2015. APOL1 Kidney Disease Risk Variants: An Evolving Landscape.
24119848 2013. APOL1 and nephropathy progression in populations of African ancestry.
20347640 2010. Genetic basis of nondiabetic end-stage renal disease.
28795137 2017. Late Reoccurrence of Collapsing FSGS After Transplantation of a Living-Related Kidney Bearing APOL 1 Risk Variants Without Disease Evident in Donor Supports the Second Hit Hypothesis.
30371607 2019. Mechanisms of Injury in APOL1-associated Kidney Disease.
26947522 2016. Apolipoprotein L1 and Kidney Disease in African Americans.
29886044 2018. APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.
11863085 2002. Focal segmental glomerulosclerosis in African Americans.
22952321 2012. Collapsing glomerulopathy associated lupus in a black female with homozygous APOL1 mutation.
